Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Scotiabank Maintains Sector Outperform on Agios Pharmaceuticals, Lowers Price Target to $71

Author: Benzinga Newsdesk | May 02, 2025 10:16am

Scotiabank analyst Greg Harrison maintains Agios Pharmaceuticals (NASDAQ:AGIO) with a Sector Outperform and lowers the price target from $74 to $71.

Posted In: AGIO